日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

SENP3 inhibition suppresses hepatocellular carcinoma progression and improves the efficacy of anti-PD-1 immunotherapy

SENP3抑制剂可抑制肝细胞癌进展并提高抗PD-1免疫疗法的疗效

Wang, Peng; Qiu, Jiannan; Fang, Yuan; Li, Songmao; Liu, Kua; Cao, Yin; Zhang, Guang; Wang, Zhongxia; Gu, Xiaosong; Wu, Junhua; Jiang, Chunping

Correction: SENP3 inhibition suppresses hepatocellular carcinoma progression and improves the efficacy of anti-PD-1 immunotherapy

更正:SENP3抑制剂可抑制肝细胞癌进展并提高抗PD-1免疫疗法的疗效

Wang, Peng; Qiu, Jiannan; Fang, Yuan; Li, Songmao; Liu, Kua; Cao, Yin; Zhang, Guang; Wang, Zhongxia; Gu, Xiaosong; Wu, Junhua; Jiang, Chunping

Hepatic NMNAT1 is required to defend against alcohol-associated fatty liver disease.

肝脏NMNAT1是抵御酒精相关性脂肪肝疾病所必需的

Ding Qinchao, Cao Feiwei, Zhuge Hui, Lai Shanglei, Cao Wenjing, Wei Haibin, Guo Rui, Qiu Jiannan, Song Qing, Pei Liuhua, Li Chaolan, Si Caijuan, Sun Zhaoli, Song Zhenyuan, Dou Xiaobing, Li Songtao

Pachymic acid alleviates metabolic dysfunction-associated steatotic liver disease by inhibiting ferroptosis through PPARα.

帕奇米酸通过抑制 PPARα 介导的铁死亡来缓解代谢功能障碍相关的脂肪肝疾病

Ren Guilin, Lin Yiyou, Qiu Jiannan, Zhang Congcong, Chen Lin, Zhu Linwensi, Fan Xiaohui, Dou Xiaobing, Liu Qingsheng

Bifidobacterium bifidum reduces oxidative stress and alters gut flora to mitigate acute liver injury caused by N-acetyl-p-aminophenol

双歧杆菌可降低氧化应激并改变肠道菌群,从而减轻N-乙酰对氨基苯酚引起的急性肝损伤。

Yin, Juan; Chen, Lin; Lin, Yiyou; Qiu, Jiannan; Liu, Fucai; Wang, Yuhao; Dou, Xiaobing

FBXO42 promotes hepatocellular carcinoma progression via mediating p57Kip2 ubiquitination and degradation

FBXO42通过介导p57Kip2的泛素化和降解来促进肝细胞癌的进展。

Zhou, Bing; Wu, Shasha; Hong, Shengqian; Li, Han; Jiang, Zhi; Sun, Yong; Qiu, Jiannan; Qin, Lei

Loss of macrophage TSC1 exacerbates sterile inflammatory liver injury through inhibiting the AKT/MST1/NRF2 signaling pathway

巨噬细胞TSC1的缺失通过抑制AKT/MST1/NRF2信号通路加剧无菌性炎症性肝损伤

Ni, Ming; Qiu, Jiannan; Liu, Guoqing; Sun, Xiaohu; Zhu, Wenjie; Wu, Peng; Chen, Zheng; Qiu, Jiajing; Wu, Ziming; Zhang, Yang; Zhang, Feng; Li, Changyong; Gao, Yuan; Zhou, Jun; Zhu, Qiang

miR-488-5p mitigates hepatic stellate cell activation and hepatic fibrosis via suppressing TET3 expression

miR-488-5p通过抑制TET3表达来减轻肝星状细胞活化和肝纤维化。

Qiu, Jiannan; Wu, Shasha; Wang, Peng; Zhou, Yan; Wang, Zhongxia; Sun, Yong; Jiang, Chunping

Novel Nomograms Based on Gamma-Glutamyl Transpeptidase-to-Lymphocyte Ratio Predict Prognosis of Hepatocellular Carcinoma Patients After Hepatectomy

基于γ-谷氨酰转肽酶与淋巴细胞比值的新型列线图预测肝细胞癌患者肝切除术后的预后

Ma, Cheng; Cao, Yin; Zhang, Guang; Qiu, Jiannan; Zhou, Yan; Wang, Peng; Wang, Shuo; Yan, Dongliang; Ma, Ding; Jiang, Chunping; Wang, Zhongxia

FSTL1 promotes liver fibrosis by reprogramming macrophage function through modulating the intracellular function of PKM2

FSTL1通过调节PKM2的细胞内功能,重编程巨噬细胞功能,从而促进肝纤维化。

Rao, Jianhua; Wang, Hao; Ni, Ming; Wang, Zeng; Wang, Ziyi; Wei, Song; Liu, Mu; Wang, Peng; Qiu, Jiannan; Zhang, Lei; Wu, Chen; Shen, Hongbing; Wang, Xuehao; Cheng, Feng; Lu, Ling